AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | N022063 | TAKEDA PHARMACEUTICALS USA INC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2017-00665 | 8846100 | IPR | Amerigen Pharmaceuticals Limited | Terminated-Settled | 2017-01-13 | — |
| IPR2018-00290 | 8846100 | IPR | KVK-Tech, Inc. et al. | Final Written Decision | 2017-12-11 | — |
| IPR2018-00293 | 9173857 | IPR | KVK-Tech, Inc. et al. | Final Written Decision | 2017-12-11 | — |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Shire Development LLC et al v. Teva Pharmaceuticals USA, Inc. et al 3 patentsANDA 210876Mixed salts of a single-entity amphetamine | D. Del. | 2017-11-22 | Terminated 2019-11-08 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).